New York, NY, USA, 04/27/2016 /SubmitPressRelease123/

The Apple iCloud Activation Lock is a feature that allows users to lock down an iPhone (or iPad). It requires the entry of an Apple ID before the device can be used again. It’s part of the excellent “Find My iPhone” service and is extremely useful for many reasons. But it can also be a real pain if you or someone else obtains an iPhone that has another Apple ID attached to it. That iPhone is then ‘locked’ with an activate request, which can only be unlocked by the previous account that was registered on it. Only once the activation lock is removed, the device can be used with another Apple ID.

How to Remove & Bypass iCloud Lock? Many users are searching for a working way to bypass & remove iCloud Account Activation Lock on iPhone 6S, 6, 6 Plus, 5S, 5C, 5, 4S and iPad Air/Mini 4, 3, 2 iOS 9, 9.2, 9.3.1/iOS 10. The good news is that a new software is now available from iCloud Remover. Since the iPhone is a very popular device, the iCloud Activation Lock is a common problem that most users have. It can happen to anyone due to many different reasons. For example, there are many users who may have this problem (with the activation lock feature) simply because they bought a used iPhone device either online or from a second hand retailer. Normally the seller is required to provide the Apple ID and password along with the device, but unfortunately in many situations this is not the case. If you ever decide to buy a used iPhone don’t forget to ask for the Apple login credentials.

iCloud Remover is a company that allow users to turn off/disable and bypass the iCloud activation lock. This new software works not only on all iPhone models but also on iPads as well.

You should turn OFF all of the services that are shown here, as you may not want to sync other data, and then toggle ON the “Find My iPhone” service. You will then be shown a prompt indicating that this will disable “Find My iPhone” for the primary account, as this feature can only be used with a single iCloud account at a time.

The new software will disable and remove iCloud Lock for anyone who has a device linked to it. Regardless of whether it is due to the fact that you are locked out of your own unit (and are in a place like Saudi Arabia, which has no Apple Store to present invoice),or that you bought a used unit from a seller who did not remove their iCloud login details from it (intentionally or unintentionally).

Contact:
Company Official Website: iCloudRemover.org
E-mail: info@icloudremover.org

Like Us on Facebook

Read the full story at http://newsreleases.submitpressrelease123.com/2016/04/29/company-released-easiest-bypass-icloud-activation-lock-iphone-6s6-5s-ipad-air/

ReleaseID: 19363

April 29, 2016 – – TheProductLawyers.com comments on reports of the consolidation of federally-filed Cook IVC filter lawsuits which was ordered in October 2014 by the U.S. Judicial Panel on Multidistrict Litigation. The lawsuits now form an MDL and be will overseen in a single Court in the Southern District of Indiana, helping to “fast track” the litigation process. Since this MDL’s formation, plaintiffs who have filed these lawsuits and defendant Cook Medical have been preparing for the initial cases to be heard at trial. This is scheduled to take place beginning in September of 2016.

The court reported that a settlement conference was once scheduled for March of 2016. At this conference, involved parties were supposed be able to talk about negotiating potential settlement options with each other in front of a U.S. magistrate judge. The conference was pushed back once, and now once again as Cook has reportedly requested another 60 day postponement so that their counsel is able to conduct further investigations and research. This motion was said to have been submitted to the court on February 9th of 2016, which means that the conference may take place in early May.

At this time, the current case listing includes over 250 lawsuits which are pending in the MDL, and many expect that additional lawsuits which will join the MDL will be filed over the next few months. Plaintiffs anxiously awaiting the settlement conference are hopeful that it might facilitate successful negotiations and that a resolution may be able to be reached between the parties without trial.

Plaintiffs filing the Cook IVC filter lawsuits similarly allege that the device is defectively designed and manufactured. They share claims that the cage-like filters can actually move from their original inferior vena cava vein insertion points, and break apart or travel within the body, causing additional damage. Several patients report that the filters are still within their body, and are unable to be surgically removed due to becoming embedded in areas that surgeons deem “high-risk.” These plaintiffs sometimes compare themselves to ticking time bombs, and indicate that they consistently live with fear that the filter will move again and cause life-threatening damage.

As time goes on, the attorneys of Banville Law are currently working to help other patients who feel that their health has been negatively impacted by an IVC filter device. Affected patients could be entitled to significant compensation, and are greatly encouraged to take advantage of the opportunity to fully evaluate their legal rights in the matter. Banville Law is now offering free legal consultations to affected parties who wish to further explore these options.

To request further information on IVC filter lawsuits, or to ask questions, contact the attorneys of Banville Law by calling 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009701

April 29, 2016 – – LegalHerald.com reports on a verdict that was handed down last November for a lawsuit filed under case number 130401990. The complaint discussed antipsychotic drug Risperdal, and the drug’s possible connection to the development of gynecomastia among male patients. Gynecomastia is a condition which causes significant breast tissue development among men, therefore developing breasts that resemble those of a female. The claims have been upheld in the Court of Common Pleas in Philadelphia, Pennsylvania. It was reported, however, that a hearing on March 10th reduced the amount rewarded to the plaintiff from $1.75 million to $680,000.

Risperdal is a potent antipsychotic drug which is manufactured by Johnson & Johnson division Janssen Pharmaceuticals. It has been reported that the corporation is facing over 1,700 lawsuits referencing Risperdal at this time. The lawsuits have been transferred and consolidated to form a mass tort program in Philadelphia, Pennsylvania, which is now underway. The complaints consolidated in the mass tort have reportedly been filed on behalf of patients who have taken the drug and who have subsequently suffered from gynecomastia or other complications. Plaintiffs involved share common allegations that the side effects were caused by Risperdal, and believe that Johnson & Johnson could have intentionally hidden the potential of these side effects from patients and medical professionals. They also commonly claim that Johnson & Johnson was negligent in failing to properly warn doctors and consumers about the possibility of these negative side effects according to case number 100300296 of the Risperdal Litigation.

It has been indicated that current litigation has seen a total of four trials which surrounded allegations made against Risperdal and its possible link to gynecomastia. Plaintiffs in three out of these four trials have won, and have been awarded significant financial compensation. These plaintiffs have expressed that Risperdal side effects not only physically hurt them, but also caused them to suffer from severe emotional trauma as well. Plaintiffs who have developed severe gynecomastia note that surgery is their only option to attain a “normal” male body again.

The attorneys of Banville Law are currently working to help other patients who have used Risperdal and who believe that the drug has negatively impacted their health. They wish to ensure that these patients are provided an opportunity to fully investigate their legal rights in the matter, as they may be entitled to significant compensation. To better assist these patients, Banville Law is now offering free legal consultations for qualified parties. They also sponsor a website designed to keep the public informed of important information and updates surrounding the drug.

To request further Risperdal lawsuit information, or to ask questions, contact the attorneys of Banville Law by calling 888-997-3792.

###

Contact Banville Law:

Laurence Banville, Esq.
888-997-3792
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60009700

April 29, 2016 – – BloodThinnerHelp.com discusses information from yet another Xarelto-related lawsuit filed against manufacturers Bayer AG and Janssen Pharmaceuticals (a subdivision of Johnson & Johnson corporation), as well as multiple other defendants. The plaintiff filing the lawsuit alleges that use of the new-generation blood-thinning drug caused him to suffer from an unexpected and severe bleeding event. His lawsuit was transferred to be consolidated with thousands of others in a move by the U.S. Judicial Panel on Multidistrict Litigation, forming MDL 2592. Today, MDL 2592 involves over 2,800 complaints which all commonly allege the dangers of Xarelto. The cases are being overseen in Eastern Louisiana by Judge Eldon E. Fallon.

This lawsuit is especially notable as it involves 90-counts and requests a large monetary compensation: $4.35 million. The plaintiff alleges that defendants purposefully marketed Xarelto in misleading ways to display it as both safe and effective, while neglecting to properly address potential dangerous side effects which have been linked to its use. Other plaintiffs have also drawn attention to Xarelto marketing tactics, and have noted the use of celebrity endorsements and potentially misleading information.

This lawsuit plaintiff, however, addresses the fact that the drug’s manufacturers had likely been previously aware that their drug could cause serious bleeding risks for patients using it, and he offers supporting evidence for this case. The man noted, “Defendants use the results of the Rocket AF study, the Record studies, and the Einstein studies to promote Xarelto in their promotional materials, including the Xarelto website, which tout the positive results of those studies. However, defendants’ promotional materials fail to similarly highlight the increased risk of gastrointestinal bleeding and bleeding that required transfusion among other serious bleeding concerns.”

Similar allegations surrounding Xarelto have been made through adverse event reports to the FDA, and additional controversies surrounding the FDA’s approval of the drug have recently spawned an investigation by European Regulators. Prior information has shown that Xarelto manufacturers spent over $11 million to promote the drug, and that their tactics brought in an estimated $582 million in revenue in the drug’s first year on the market alone. Xarelto was approved and released to market just 5 years ago, in 2011, and has since become the subject of more than 3,400 lawsuits from across America. Lawsuits concerning the drug have now been filed in Canada as well.

Attorney Joseph Osborne is working to help other patients who have used Xarelto and who feel that the drug has negatively impacted their health. He wants to ensure that all affected patients will be given an opportunity to fully investigate their legal rights in the matter, as they could be entitled to significant compensation. To help patients desiring to learn more about their legal options, Attorney Osborne is now offering free legal consultations for qualified parties.

To request additional information, or to ask questions, please contact Attorney Osborne by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60009699

April 29, 2016 – – Many people read about the Law of Attraction but never quite figure out how to make it work for them. Elisabeth Kuhn, Ph.D., the owner of the blog My Favorite Self Help Stuff DOT Com, now offers a free 5-step guide to Manifesting Abundance. She also provides a number of tips in her article that can provide important clues why things often aren’t working so well.

Kuhn argues that it is all too easy to fall into the trap of focusing on what needs to be changed. This means, of course that the focus is on what people do not want. Unfortunately, this approach only attracts more of what they don’t want.

Instead, they need to focus on what they do want. This can be difficult when they’re mired in frustration, but it’s definitely worth the effort. After all, she argues, it is feelings that attract things, and not our words, at least not for the most part.

In her article on Manifesting Abundance, Kuhn offers five keys to achieving a more successful outcome. She also points out several traps that are easy to fall into and that could keep anyone stuck in the mud. She shares how she, too, used to fall into the same trap and feel quite self-righteous when insisting that she would be happy just as soon as her life improved. But a mentor told her it’s the other way round. She first had to be happy and then things would improve.

Following those principles is not easy, but there are ways to make it less challenging. Kuhn’s article provides some suggestions, and a free guide on Manifesting Abundance provides additional help.

There is also a resource available that provides a much more detailed path towards abundance, both in terms of information and in terms of literally helping with making more abundance happen. That’s because this resource is a complete business in a box with Private Label Rights. It not only provides lots of valuable information, but it can also be uploaded and sold immediately.

More details as well as well as the free guide on Manifesting Abundance and the not quite free but very affordable resource with PLR rights are available at the end of Kuhn’s article on her blog, MyFavoriteSelfHelpStuff.com.

http://myfavoriteselfhelpstuff.com/manifesting-abundance-how-to-get-what-you-want/

###

Contact My Favorite Self Help Stuff:

Elisabeth Kuhn
804-285-2535
richmondwebmarketing@gmail.com
My Favorite Self Help Stuff
c/o Elisabeth Kuhn
P.O. Box 17912
Richmond, VA 23226

ReleaseID: 60009704

April 29, 2016 – – EUGENE, Ore., April 27, 2016—When attempting to hire and fill positions, employers nationwide have experienced a similar increasing problem. Express Employment Professionals, one of the premium staffing agencies in Eugene, OR, recently released brand-new study results revealing this issue.

The findings originate from a study of 340 companies. Participants were asked, “Currently, how easy is it for you to recruit and fill positions?”

Just 3 percent said “very easy,” while 29 percent said “somewhat easy.” Virtually half, 49 percent, said “somewhat difficult,” 16 percent said “very difficult,” and another three percent said, “I don’t know.”

More participants stated “very difficult” or “somewhat difficult” (65 percent) in this survey than in any of the four hiring trends studies conducted by Express in 2015. The increase in reported difficulty corresponds with the decrease in the unemployment rate.

“As the unemployment rate lowers, it has been increasing difficult for businesses to fill certain positions,” said Renee Loheed, branch manager of the Eugene Express office. “Our main goal at Express is to provide employment in Eugene, OR and we have thus seen steady growth with our assistance in the community.”

The survey of 340 companies, which are previous and present clients of Express Employment Professionals, covers hiring trends for the first quarter of 2016.

Those would like to request for an interview with Express Employment Professionals in Eugene, OR are encouraged to call (541) 214-2629.

About Express Employment Professionals
Express Employment Professionals puts people to work. It generated $3.02 billion in sales and employed a record 500,002 people in 2015. Its long-term goal is to put a million people to work annually.

The Eugene Express office is located at 945 Garfield St., Eugene, OR 97402 and serves the Lane County area. Local businesses and applicants are encouraged to stop by, visit https://expresspros.com/eugeneor or call (541) 214-2629.

###

Contact Express Employment Professionals – Eugene, OR:

Renee Loheed
Express.Eugene@gmail.com
945 Garfield St.
Eugene, OR 97402

ReleaseID: 60009692

April 29, 2016 – – TheProductLawyers.com coments on claims made in recent lawsuits filed against various IVC filter brands. IVC filters are implanted in patients who are considered at risk for blood clot development but who cannot take traditional blood thinners. The filters are surgically implanted into the inferior vena cava vein of patients, and are intended to catch and hold blood clots until they dissipate, preventing them from traveling into the heart and lungs, where they could cause pulmonary embolism or other serious complications. Over the last 30 years, these filters have become much more heavily used. Reports indicate that in 1979, only 2,000 patients were implanted with the filters, but, by 2007, the filters had been implanted into 167,000 patients.

Recent lawsuits referencing the device as well as public safety communications issued by the U.S. Food and Drug Administration (FDA), have begun to bring new controversies to light concerning the use of IVC filters. Emerging medical research has also shown several possibly life-threatening risks connected to IVC filter use. Plaintiffs currently involved in lawsuits filed regarding the products allege that they are dangerous and defectively designed, and that the filters can dislodge from their original insertion points, break apart, and migrate within the body, perforating veins and blood vessels, and becoming lodged within internal organs or intestines, causing severe health concerns.

These allegations have prompted a number of patients to question whether the filters are ‘worth the risk’, and whether they are truly successful at preventing deep vein thrombosis as intended. Several study results have caused additional alarm by indicating that IVC filters may not actually present any benefits for patients using them over taking blood-thinning drugs after all.

These concerns were evaluated by a JAMA publication called, “The Inferior Vena Cava Filter: How Could A Medical Device Be So Well Accepted Without Any Evidence Of Efficacy?” In the publication, it was indicated that despite the fact that the filters should theoretically work, their actual proven benefits have, “never been validated by empirical studies.”

The attorneys of Banville Law are concerned by these new questions as well, and are working to help other patients who believe their health has been negatively impacted or is currently being negatively impacted by an IVC filter device. Banville Law is working to ensure that all affected patients will be provided with an opportunity to fully evaluate their legal rights in the matter, as they may be entitled to substantial compensation. Patients who wish to further investigate their legal options are also offered free legal consultations from the law firm at this time.

To request additional information, or to ask questions, contact the attorneys of Banville Law by calling 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009696

April 29, 2016 – – BloodThinnerHelp.com reports on the scheduled bellwether lawsuit trials for lawsuits consolidated in Xarelto multidistrict litigation number 2592. Bellwether trials will hear 4 cases chosen from a bellwether pool of 40 which are intended to best represent all plaintiffs who have currently filed Xarelto-related lawsuits. The hearings are intended to provide all involved with a better idea of how juries might react to certain pieces of evidence and testimony moving forward. Lawsuits involved in MDL 2592 currently number over 2,800 and are being overseen in Eastern Louisiana by the Honorable Judge Eldon Fallon. They share strikingly similar plaintiff allegations made against defendants Bayer AG and Johnson & Johnson’s subsidiary company Janssen Pharmaceuticals.

In 2011, Xarelto launched onto the market after gaining approval by the U.S. Food and Drug Administration. The drug was a revolutionary, new-generation blood thinner which was able to provide patients with freedoms that other blood thinners had been unable to. Unlike traditional blood thinners, Xarelto required no special diets, dosage adjustments, or regular monitoring and check-ins with a physician. It also, however, was released to market with no corresponding antidote; a dangerous move that many plaintiffs today call recklessly negligent.

Xarelto remained on the market without any antidote for over 4 years, according to reports. Patients taking the drug, therefore, had to be very careful of being injured while on it, which is sometimes hard to avoid. Without an antidote to clot the blood and counter the effects of Xarelto, even a minor injury could become life-threatening due to blood loss. Traditional blood thinners offer a corresponding antidote through vitamin K. When patients using these blood thinners injure themselves and begin to bleed, doctors are able to counter the blood thinner’s effects with vitamin K and clot their blood, potentially saving their lives.

Since this time, Xarelto has been linked to increased risk of serious and potentially fatal bleeding events by the thousands of plaintiffs filing lawsuits. As these plaintiffs await trial dates, Attorney Joseph Osborne is working to help other patients who have used Xarelto and who feel that the drug has caused them to suffer from health complications. Those affected may be entitled to substantial compensation gained through legal action, and are encouraged to take the opportunity to explore their legal rights in the matter fully. Those who wish to look into their options further are offered complimentary legal consultations at this time from Attorney Osborne.

To request additional information, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60009694

April 29, 2016 – – CENTRALIA, Wash., April 27, 2016— Express Employment Professionals just revealed fresh survey results exposing the escalating difficulty that employers face when striving to recruit and fill positions. Employment agencies in Centralia, WA have noticed these changes and begun taking action to help build their community.

The final results emerged from a survey of 340 companies. Contributors were asked, “Currently, how easy is it for you to recruit and fill positions?”

Only three percent said “very easy,” while 29 percent said “somewhat easy.” About half, 49 percent, said “somewhat difficult,” 16 percent said “very difficult,” and an additional three percent said, “I don’t know.”

More participants said “very difficult” or “somewhat difficult” (65 percent) in this specific survey than in any of the four hiring trends surveys conducted by Express in 2015. The development in reported difficulty corresponds with the fall in the unemployment rate.

“Our market has been noticing these changes and growing to make adjustments to better suit the community,” said Matthew Rice-Swena, branch manager of the Centralia Express office. “We work closely with our clients and job seekers to continue to provide jobs in Centralia, WA.”

The survey of 340 businesses, which are current and past clients of Express Employment Professionals, covers hiring patterns for the first quarter of 2016.

The company encourages anyone who would like to arrange for an interview with Express Employment Professionals in Centralia, WA to call (360) 388-4012.

About Express Employment Professionals
Express Employment Professionals puts people to work. It generated $3.02 billion in sales and employed a record 500,002 people in 2015. Its long-term goal is to put a million people to work annually.

The Centralia Express office is located at 1126 S Gold St. #102, Centralia, WA 98531 and serves the Lewis County area. Local businesses and applicants are encouraged to stop by, visit https://www.expresspros.com/CentraliaWA or call (360) 388-4012.

###

Contact Express Employment Professionals – Centralia, WA:

Matthew Rice-Swena
(360) 388-4012
Express.Centralia@Gmail.com
1126 South Gold St., Suite 102
Centralia, WA 98531

ReleaseID: 60009693

April 29, 2016 – – TheProductLawyers.com reports on a recent article by Fierce Medical Devices indicating that Johnson & Johnson is looking to cut 3,000 jobs in its medical device unit in order to save up to $1 billion in costs by 2018. According to the article, the cuts comprise about 6 percent of the company’s medical device unit and sales for their medical devices dropped 2.9% during the first 9 months of 2015.

The company, along with C.R. Bard, Cook Medical, Boston Scientific and Coloplast Corp has been facing thousands of lawsuits related to transvaginal mesh, one of their medical devices. The mesh, usually made of synthetic polypropylene, is typically used in pelvic organ prolapse or stress urinary incontinence procedures to support bulging organs and the urethra. The devices were first approved by the FDA in 1996 for stress urinary incontinence and then in 2002 for pelvic organ prolapse. Since then, the FDA has received thousands of adverse events reports and modified the device from “moderate risk” to “high risk.”

Many women have come forward claiming not only that the devices are defective and cause serious side effects but that the companies were aware of these flaws and did not attempt to remedy them. Plaintiffs in those cases have claimed that the devices cause bleeding, organ perforation, urinary tract infections, inability to engage in sexual intercourse, severe pelvic or vaginal pain, vaginal scarring, emotional problems, nerve damage, vaginal shrinkage and erosion of mesh through the vagina. There are currently over 70,000 cases filed in the U.S., some of which have resulted in millions of dollars in settlements for defendants.

As these cases are expected to accumulate, lawyers at Banville Law are working to ensure that those individuals who have been treated with transvaginal mesh are able to explore their legal rights fully. Qualifying individuals may be entitled to legal action and substantial financial compensation. The firm is currently offering free case evaluations for interested parties.

For more information, or to ask questions about transvaginal mesh, contact Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009681